posted on 2018-06-06, 09:33authored byRajko Reljic, Simon D. Wagner, Luke J. Peakman, Douglas T. Fearon
Lymphocytes usually differentiate into effector cells within days after antigen exposure, except in germinal centers where terminal differentiation is delayed while somatic hypermutation creates high-affinity antibody mutants. Here we investigate whether arrest of terminal differentiation can be mediated by BCL-6, a transcriptional repressor that is expressed by germinal center B cells and is required for this phase of B cell development. We find that BCL-6 suppresses the differentiation of transformed and primary B cells to plasma cells by inhibiting the signal transducer and activator of transcription 3-dependent expression of the major regulator of plasma cell development, the B lymphocyte-induced maturation protein (Blimp-1). This function of BCL-6 as a repressor of B lymphocyte differentiation may also underlie the association between chromosomal translocations of its gene and B cell lymphomas.
Funding
This project was funded by the Wellcome Trust. S.D. Wagner is a
recipient of the Royal Society Rink Fellowship, and D.T. Fearon is
a Wellcome Trust Principal Research Fellow.
History
Citation
Journal of Experimental Medicine, 2000, 192 (12), pp. 1841-1848
Author affiliation
/Organisation/COLLEGE OF MEDICINE, BIOLOGICAL SCIENCES AND PSYCHOLOGY/School of Medicine/Department of Cancer Studies and Molecular Medicine